BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012;19:9-22. [PMID: 22187943 DOI: 10.1111/j.1365-2893.2011.01511.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lavanchy D, Kane M. Global Epidemiology of Hepatitis B Virus Infection. In: Liaw Y, Zoulim F, editors. Hepatitis B Virus in Human Diseases. Cham: Springer International Publishing; 2016. pp. 187-203. [DOI: 10.1007/978-3-319-22330-8_9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
2 Chaouch H, Hachfi W, Fodha I, Kallala O, Saadi S, Bousaadia A, Lazrag F, Bougmiza I, Aouni M, Trabelsi A, Ben Jazia E, Letaief A. Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia. Epidemiol Infect 2016;144:3365-75. [PMID: 27535719 DOI: 10.1017/S0950268816001849] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
3 Su T, Kao J. Improving clinical outcomes of chronic hepatitis B virus infection. Expert Review of Gastroenterology & Hepatology 2014;9:141-54. [DOI: 10.1586/17474124.2015.960398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
4 Fathi M, Saeid Rezaee-zavareh M, Sharafi H, Hesamizadeh K, Karimi-sari H, Alavian SM, Karimi J. Tehran Hepatitis Conference: An International Meeting with the Goal of Middle East without Viral Hepatitis. Hepat Mon 2016;16. [DOI: 10.5812/hepatmon.40539] [Reference Citation Analysis]
5 Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21:1020-6. [PMID: 26163105 DOI: 10.1016/j.cmi.2015.06.028] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
6 Aljumah AA, Kuriry H, AlZunaitan M, Al Ghobain M, Al Muaikeel M, Al Olayan A, Azzumeea F, Almutairi B, AlAlwan A, AlGhamdi H. Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience. Gastroenterol Res Pract 2016;2016:1989045. [PMID: 27525001 DOI: 10.1155/2016/1989045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42): 11941-11953 [PMID: 26576083 DOI: 10.3748/wjg.v21.i42.11941] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
8 Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, Sanai FM. Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol 2019;25:73-80. [PMID: 30720000 DOI: 10.4103/sjg.SJG_421_18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
9 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
10 Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, Saeid Mohamed AG, Elmestikawy A, Morsy MH, Hashim A, Abdelbasseer MA. Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother 2013;9:2002-6. [PMID: 23787761 DOI: 10.4161/hv.25426] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Berkhout B, Sanders RW. Gene therapy as a vaccine for HIV-1. Expert Opin Biol Ther 2012;12:1315-21. [PMID: 22803517 DOI: 10.1517/14712598.2012.707177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Keyvani H, Sohrabi M, Zamani F, Poustchi H, Ashrafi H, Saeedian F, Mooadi M, Motamed N, Ajdarkosh H, Khonsari M, Hemmasi G, Ameli M, Kabir A, Khodadost M. A population based study on hepatitis B virus in northern iran, amol. Hepat Mon 2014;14:e20540. [PMID: 25237372 DOI: 10.5812/hepatmon.20540] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 Gasim GI. Hepatitis B virus in the Arab world: where do we stand? Arab J Gastroenterol. 2013;14:35-43. [PMID: 23820498 DOI: 10.1016/j.ajg.2013.04.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
14 Demirturk N, Demirdal T. Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study. Clin Mol Hepatol 2014;20:56-60. [PMID: 24757659 DOI: 10.3350/cmh.2014.20.1.56] [Reference Citation Analysis]
15 Lo AO, Wong GL. Current developments in nucleoside/nucleotide analogues for hepatitis B. Expert Rev Gastroenterol Hepatol. 2014;8:607-622. [PMID: 24787673 DOI: 10.1586/17474124.2014.909724] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
16 Liu J, Lv J, Yan B, Feng Y, Song L, Xu A, Zhang L, Yan Y. Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China. Int J Infect Dis 2017;61:13-9. [PMID: 28577994 DOI: 10.1016/j.ijid.2017.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Bagheri-Jamebozorgi M, Keshavarz J, Nemati M, Mohammadi-Hossainabad S, Rezayati MT, Nejad-Ghaderi M, Jamalizadeh A, Shokri F, Jafarzadeh A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother 2014;10:3731-6. [PMID: 25483689 DOI: 10.4161/hv.34393] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
18 Sanai FM, Alghamdi H, Alswat KA, Babatin MA, Ismail MH, Alhamoudi WK, Alalwan AM, Dahlan Y, Alghamdi AS, Alfaleh FZ, Aljumah AA, Altraif IH, Albeladi K, Batwa F, Alshumrani W, Belhadi D, Genestier V, Abdo AA. Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia. Saudi J Gastroenterol 2019;25:194-200. [PMID: 30720002 DOI: 10.4103/sjg.SJG_447_18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
19 Ovsyannikova IG, Dhiman N, Jacobson RM, Poland GA. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Rev Vaccines 2006;5:33-43. [PMID: 16451106 DOI: 10.1586/14760584.5.1.33] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
20 Kupek E. Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives. ISRN Infectious Diseases 2013;2013:1-15. [DOI: 10.5402/2013/839896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Assis DR, Tenore Sde B, Pinho JR, Lewi DS, Ferreira PR. Characteristics of an outpatient chronic hepatitis B virus infection cohort. Einstein (Sao Paulo) 2015;13:189-95. [PMID: 26154539 DOI: 10.1590/S1679-45082015AO3269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, Vanlandschoot P, Desombere I. Prevention of hepatitis B infections: vaccination and its limitations. Acta Clin Belg. 2001;56:209-219. [PMID: 11603250 DOI: 10.1179/acb.2001.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
23 Elrashidy H, El-Didamony G, Elbahrawy A, Hashim A, Alashker A, Morsy MH, Elwassief A, Elmestikawy A, Abdallah AM, Mohammad AG. Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Hum Vaccin Immunother. 2014;10:2336-2341. [PMID: 25424940 DOI: 10.4161/hv.29521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Abaalkhail FA, Al-Hamoudi WK, Khathlan A, Alghamdi S, Alghamdi M, Alqahtani SA, Sanai FM. SASLT practice guidelines for the management of Hepatitis B virus - An update. Saudi J Gastroenterol 2021;27:115-26. [PMID: 33976009 DOI: 10.4103/sjg.sjg_539_20] [Reference Citation Analysis]
25 Bestas R, Yalcin K. Clinical and Virological Features of Acute Hepatic Exacerbations in Patients With Chronic Hepatitis B Virus Infection. Cureus 2021;13:e15937. [PMID: 34194888 DOI: 10.7759/cureus.15937] [Reference Citation Analysis]